AGIO icon

Agios Pharmaceuticals
AGIO

Overview Fund Activity

196 hedge funds and large institutions have $2.66B invested in Agios Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 79 increasing their positions, 55 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
196
Holders Change
-12
Holders Change %
-5.77%
% of All Funds
4.37%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
28
Increased
79
Reduced
55
Closed
40
Calls
$42.5M
Puts
$17.2M
Net Calls
+$25.3M
Net Calls Change
+$20.1M

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$41.3M
2
BB
2
BB Biotech
Switzerland
$133M
3
WIM
3
Woodford Investment Management
United Kingdom
$91.2M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$213M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$375M

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
Wells Fargo
2
Wells Fargo
California
$6.69M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$108M
4
Loomis, Sayles & Company
4
Loomis, Sayles & Company
Massachusetts
$0
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$8.43M
Name Holding Trade Value Shares
Change 		Shares
Change %
AIL
226
AGF Investments LLC
Ontario, Canada
– -$8K -104 Closed
Fifth Third Bancorp
227
Fifth Third Bancorp
Ohio
– -$6K -83 Closed
SPIA
228
Steward Partners Investment Advisory
New York
– -$1K -9 Closed
Federated Hermes
229
Federated Hermes
Pennsylvania
– -$1K -8 Closed
MFT
230
Moisand Fitzgerald Tamayo
Florida
– -$48K – –
6 7 8 9
10